The Design and Development of Pegfilgrastim (PEG-rmetHuG-CSF, Neulasta®)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|11|1235-1244

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.11, 2004-04, pp. : 1235-1244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegfilgrastim

By Curran M.P.   Goa K.L.  

Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. : 1207-1213

Adis International

Access to resources Recommend Favorite

G-CSF linked to GVHD

By  

Reactions Weekly, Vol. 1, Iss. 1327, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

G-CSF reduces febrile neutropenia and mortality risk

By  

Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

G-CSF as prophylaxis of febrile neutropenia in SCLC

By Feinglass Joe   Adams Jared R   Djubegovic Benjamin   Bennett Charles L   Lyman Gary H  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 9, 2002-09 ,pp. : 1273-1281

Informa Healthcare

Access to resources Recommend Favorite

G-CSF prophylaxis: when second comes first

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 650, 2012-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite